Gilead Sciences

Latest news

• More Upside Awaits for Gilead Sciences Stock. Stay Invested. (opens in a new tab)

  Barron's · Oct 2, 2026

• Confluence Investment Management LLC Cuts Position in Gilead Sciences, Inc. $GILD (opens in a new tab)

  MarketBeat · Oct 1, 2026

• Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It (opens in a new tab)

  Oct 1, 2026

• ETFs Bought $76.5 Million of Gilead Sciences (GILD) on Sept. 29 (opens in a new tab)

  GuruFocus · Oct 1, 2026

• Gilead Sciences (NASDAQ:GILD) Stock Rating Cut to "Hold" at Zacks Research (opens in a new tab)

  MarketBeat · Oct 1, 2026

• Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors (opens in a new tab)

  Yahoo Finance · Sep 30, 2026

• Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors (opens in a new tab)

  marketwatch.com · Sep 30, 2026

• CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J (opens in a new tab)

  Sep 30, 2026

• Gilead Sciences (GILD) Tests Its Multi Platform Story On Questions Around Valuation (opens in a new tab)

  Simply Wall Street · Sep 30, 2026

• Gilead Sciences (NDQ:GILD): Fighting HIV/AIDS Is Its Economic Engine (opens in a new tab)

  Stocks Down Under · Sep 29, 2026

• Gilead Sciences (NASDAQ:GILD) Stock: Stronger HIV Sales Meet Weaker Reported Earnings (opens in a new tab)

  kalkine.ca · Sep 29, 2026

• Former Gilead CIO and CSL Chief Digital & Information Officer Mark Hill Joins Sware Board of Directors (opens in a new tab)

  biospace.com · Sep 29, 2026

• Small Molecule Drug Discovery - Global Strategic Business Report Forecasts Growth from $61.5B (2024) to $100B by 2030, Profiling AstraZeneca, Gilead Sciences, Merck & Pfizer (opens in a new tab)

  Sep 29, 2026

• Can Lenacapavir Power Gilead Sciences (GILD)’s Next Growth Phase? (opens in a new tab)

  Yahoo Finance · Sep 28, 2026

• Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside? (opens in a new tab)

  Sep 28, 2026

• Gilead Sciences stock last trades at USD 152.43 on September 28, 2026 (opens in a new tab)

  AD HOC NEWS · Sep 28, 2026

• Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing? (opens in a new tab)

  Sep 28, 2026

• Gilead vs. Thermo Fisher: Which Life Sciences Stock has the Stronger Growth Outlook? (opens in a new tab)

  Sep 28, 2026

• Mirum posts phase 3 hepatitis win for ‘commercially differentiated’ challenger to Gilead, Vir (opens in a new tab)

  Fierce Biotech · Sep 28, 2026

• Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend? (opens in a new tab)

  Yahoo Finance · Sep 28, 2026

• Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income? (opens in a new tab)

  Sep 27, 2026

• Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? (opens in a new tab)

  Sep 27, 2026

• Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification? (opens in a new tab)

  Sep 27, 2026

• Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own? (opens in a new tab)

  Sep 27, 2026

• Form 4 Gilead Sciences Inc For: 26 September By Investing.com (opens in a new tab)

  Investing.com Nigeria · Sep 27, 2026

• Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Price Target of $158.78 According to Analysts (opens in a new tab)

  MarketBeat · Sep 26, 2026

• Gilead Sciences stock closes at USD 149.69, down 1.11 percent at the close (opens in a new tab)

  AD HOC NEWS · Sep 25, 2026

• UBS Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $175 (opens in a new tab)

  Moomoo · Sep 25, 2026

• Gilead Sciences, Inc. $GILD Stake Decreased by Envestnet Asset Management Inc. (opens in a new tab)

  MarketBeat · Sep 25, 2026

• Gilead Sciences stock heads into the open after a 0.4 percent gain (opens in a new tab)

  AD HOC NEWS · Sep 25, 2026